Mycobacteria, an environmental enhancer of lupus nephritis in a mouse model of systemic lupus erythematosus

Immunology

Volumn 108, Issue 1, 2003, Pages 70-78

  Hawke, Christine G ^a   Painter, Dorothy M ^b   Kirwan, Paul D ^c   Van Driel, Rosemary R ^d   Baxter, Alan G ^a  

^a CENTENARY INSTITUTE   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c Department of Microbiology and Infectious Diseases   (Australia)

^d IATIA Ltd   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; COMPLEMENT COMPONENT C3C; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MODEL; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SIMULATION; ELECTRON MICROSCOPY; FEMALE; FOCAL GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; IMMUNE COMPLEX DEPOSITION; IMMUNOGLOBULIN DEPOSITION; LUPUS ERYTHEMATOSUS NEPHRITIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MICROSCOPY; MINIMAL CHANGE GLOMERULONEPHRITIS; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; TREATMENT PLANNING;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GLOMERULONEPHRITIS; IMMUNE COMPLEX DISEASES; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; MICE; MICE, INBRED NOD; MICROSCOPY, ELECTRON; TUBERCULIN;

EID: 0037238511     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01558.x     Document Type: Article

References (38)

1. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
2. Churg J, Bernstein J, Glassock RJ. Renal Disease: Classification and Atlas of Glomerular Diseases. New York: Igaku-Shoin Medical Publishers, Inc 1995.
3. Kashgarian M. Lupus nephritis. Pathology, pathogenesis, clinical correlations and prognosis. In: Wallace, DJ, Hahn, BH, eds. Dubois' Lupus Erythematosus. Baltimore: Williams & Wilkins 1997:1037-51.
4. Baldwin DS, Gluck MC, Lowenstein J, Gallo GR. Lupus nephritis. Clinical course as related to morphologic forms and their transitions. Am J Med 1977; 62:12-30.
5. Appel GB, Valeri A. The course and treatment of lupus nephritis. Annu Rev Med 1994; 45:525-37.
6. Theofilopoulos AN, Kofler R, Singer PA, Dixon FJ. Molecular genetics of murine lupus models. Adv Immunol 1989; 46:61-109.
7. Vyse TJ, Kotzin BL. Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol 1998; 16:261-92.
8. Tan FK, Arnett FC. The genetics of lupus. Curr Opin Rheumatol 1998; 10:399-408.
9. Cameron HA, Ramsay LE. The lupus syndrome induced by hydralazine: a common complication with low dose treatment. Br Med J (Clin Res Ed) 1984; 289:410-2.
10. Ansel JC, Mountz J, Steinberg AD, DeFabo E, Green I. Effects of UV radiation on autoimmune strains of mice: increased mortality and accelerated autoimmunity in BXSB male mice. J Invest Dermatol 1985; 85:181-6.
11. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991; 34:1538-45.
12. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985; 37:269-390.
13. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356:314-7.
14. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76:969-76.
15. Foster MH. Relevance of systemic lupus erythematosus nephritis animal models to human disease. Semin Nephrol 1999; 19:12-24.
16. Bigazzi PE. Autoimmunity and heavy metals. Lupus 1994; 3:449-53.
17. Satoh M, Kumar A, Kanwar YS, Reeves WH. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci USA 1995; 92:10934-8.
18. Harada M, Kishimoto Y, Makino S. Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res Clin Pract 1990; 8:85-9.
19. Baxter AG, Healey D, Cooke A. Mycobacteria precipitate autoimmune rheumatic disease in NOD mice via an adjuvant-like activity. Scand J Immunol 1994; 39:602-6.
20. Baxter AG, Horsfall AC, Healey D, Ozegbe P, Day S, Williams DG, Cooke A. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology 1994; 83:227-31.
21. Jordan MA, Silveira PA, Shepherd DP et al. Linkage analysis of systemic lupus erythematosus induced in diabetes-prone nonobese diabetic mice by Mycobacterium bovis. J Immunol 2000; 165:1673-84.
22. Hoffsten PE, Hill CL, Klahr S. Studies of albuminuria and proteinuria in normal mice and mice with immune complex glomerulonephritis. J Laboratory Clin Med 1975; 86:920-30.
23. Hvala A, Kobenter T, Ferluga D. Fingerprint and other organised deposits in lupus nephritis. Wien Klin Wochenschr 2000; 112:711-5.
24. Howie JB, Helyer BJ. The immunology and pathology of NZB mice. Adv Immunol 1968; 9:215-66.
25. Channing AA, Kasuga T, Horowitz RE, Dubois EL, Demopoulos HB. An ultrastructural study of spontaneous lupus nephritis in the NZB-BL-NZW mouse. Am J Pathol 1965; 47:677-94.
26. Murphy ED, Roths JB. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum 1979; 22:1188-94.
27. Hollcraft RM, Dubois EL, Lundberg GD, Chandor SB, Gilbert SB, Quismorio FP, Barbour BH, Friou GJ. Renal damage in systemic lupus erythematosus with normal renal function. J Rheumatol 1976; 3:251-61.
28. Grande JP, Balow JE. Renal biopsy in lupus nephritis. Lupus 1998; 7:611-7.
29. Rudofsky UH, Lawrence DA. New Zealand mixed mice: a genetic systemic lupus erythematosus model for assessing environmental effects. Environ Health Perspect 1999; 107 (Suppl. 5):713-21.
30. Horsfall AC, Howson R, Silveira P, Williams DG, Baxter AG. Characterization and specificity of B-cell responses in lupus induced by Mycobacterium bovis in NOD/Lt mice. Immunology 1998; 95:8-17.
31. Kelley VE, Roths JB. Interaction of mutant lpr gene with background strain influences renal disease. Clin Immunol Immunopathol 1985; 37:220-9.
32. Abedi-Valugerdi M, Hansson M, Moller G. Genetic control of resistance to mercury-induced immune/autoimmune activation. Scand J Immunol 2001; 54:190-7.
33. Abedi-Valugerdi M, Moller G. Contribution of H-2 and non-H-2 genes in the control of mercury-induced autoimmunity. Int Immunol 2000; 12:1425-30.
34. Baxter AG, Mandel TE. Hemolytic anemia in non-obese diabetic mice. Eur J Immunol 1991; 21:2051-5.
35. Arai T, Noguchi K, Machida N, Sasaki M, Oki Y, Komeda K. Detection of nuclear protein antigens to antinuclear antibodies in serum of NOD mouse. Jikken Dobutsu 1989; 38:159-62.
36. Humphreys-Beher MG, Brinkley L, Purushotham KR et al. Characterization of antinuclear autoantibodies present in the serum from nonobese diabetic (NOD) mice. Clin Immunol Immunopathol 1993; 68:350-6.
37. Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1995; 13:179-200.
38. Baxter AG, Cooke A. The genetics of the NOD mouse. Diabetes-Metabolism Rev 1995; 11:315-35.